BeStock  
Stocks › Medical Devices › CBLL

Ceribell CBLL

US equityMarket cap rank #3196Medical DevicesBrain-Computer Interface
$26.59 +$0.58 (+2.23%)
Market closed · Nov 7, 6:40 am ET · Last extended-hours $26.59 0.00%
Open$25.67
Prev close$26.01
Day range$24.87 – $26.79
Volume436.4K
Market cap$1.03B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$28.10M+32.5% YoY
Operating profit-$19.98M-33.6% YoY
Net profit-$19.27M-41.2% YoY
Diluted EPS-$0.51-34.2% YoY
Free cash flow-$12.18M-63.0% YoY
Operating cash flow-$12.86M

Revenue, last 8 quarters

$17.2MSep '24$18.5MDec '24$20.5MMar '25$21.2MJun '25$22.6MSep '25$24.8MDec '25$26.5MMar '26$28.1MJun '26

Net profit, last 8 quarters

$-10.4MSep '24$-12.6MDec '24$-12.8MMar '25$-13.6MJun '25$-13.5MSep '25$-13.5MDec '25$-19.7MMar '26$-19.3MJun '26

Diluted EPS by quarter

-0.31Sep '24-0.40Dec '24-0.36Mar '25-0.38Jun '25-0.37Sep '25-0.36Dec '25-0.52Mar '26-0.51Jun '26

Free cash flow by quarter

$-9.1MSep '24$-10.3MDec '24$-11.7MMar '25$-7.5MJun '25$-11.5MSep '25$-11.0MDec '25$-20.1MMar '26$-12.2MJun '26

Annual revenue

$25.9MFY22$45.2MFY23$65.4MFY24$89.1MFY25

Profitability & balance sheet

Gross margin88.9%
Operating margin-68.6%
Net margin-64.7%
Return on equity-43.9%
Return on assets-35.3%
Return on invested capital-37.3%
Current ratio9.18
Liabilities / assets22.9%
Cash & investments$129.26M
Total debt$20.73M
Net cash (debt)$108.53M

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Electroencephalography (EEG) headbands$21.24M 75.6%
  • Electroencephalography (EEG) portal and Clarity subscriptions$6.86M 24.4%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $28.10M $26.49M $89.06M $24.78M $22.59M
Total Operating Revenue $28.10M $26.49M $89.06M $24.78M $22.59M
Cost of Revenue $2.16M $3.37M $10.79M $3.14M $2.65M
Gross Profit $25.94M $23.12M $78.27M $21.64M $19.94M
Operating Expense $45.92M $43.87M $136.68M $36.24M $34.59M
Selling and Admin Expenses $39.17M $37.71M $117.53M $31.18M $29.61M
-Selling & Marketing Expense $24.42M $22.39M $73.08M $19.06M $18.57M
-General & Admin Expense $14.76M $15.32M $44.45M $12.12M $11.04M
Research & Development $6.75M $6.16M $19.14M $5.06M $4.98M
Operating Profit -$19.98M -$20.75M -$58.40M -$14.60M -$14.65M
Net Non-Operating Interest Income (Expense) -$438,000.00 -$434,000.00 -$1.89M -$462,000.00 -$480,000.00
Non-Operating Interest Expense $438,000.00 $434,000.00 $1.89M $462,000.00 $480,000.00
Other Income (Expense) $1.15M $1.44M $6.88M $1.53M $1.66M
Other Non-Operating Income (Expenses) $1.15M $1.44M $6.88M $1.53M $1.66M
Pretax Profit -$19.27M -$19.74M -$53.41M -$13.53M -$13.47M
Tax $0.00 $0.00 $0.00 $0.00 $0.00
Net Profit -$19.27M -$19.74M -$53.41M -$13.53M -$13.47M
Profit from Continuing Operations -$19.27M -$19.74M -$53.41M -$13.53M -$13.47M
Net Income to Parent Company -$19.27M -$19.74M -$53.41M -$13.53M -$13.47M
Net Income to Common Stockholders -$19.27M -$19.74M -$53.41M -$13.53M -$13.47M
Basic EPS -$0.51 -$0.52 -$1.46 -$0.36 -$0.37
Diluted EPS -$0.51 -$0.52 -$1.46 -$0.36 -$0.37

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $166.35M $178.08M $195.80M $195.80M $199.53M
Total Current Assets $157.85M $168.91M $186.72M $186.72M $191.81M
Cash and Cash Equivalents & Short-Term Investments $129.26M $141.18M $159.26M $159.26M $168.54M
-Cash and Cash Equivalents $32.66M $45.25M $40.48M $40.48M $23.74M
-Short Term Investments $96.60M $95.93M $118.79M $118.79M $144.80M
Receivables $16.00M $15.71M $15.05M $15.05M $12.23M
-Accounts Receivable $16.00M $15.71M $15.05M $15.05M $12.23M
Inventory $6.74M $6.90M $7.29M $7.29M $6.02M
Current Deferred Assets $2.20M $2.23M $2.21M $2.21M $2.15M
Other Current Assets $3.66M $2.88M $2.91M $2.91M $2.86M
Total Non-Current Assets $8.50M $9.17M $9.09M $9.09M $7.72M
Net PPE $3.54M $3.97M $4.33M $4.33M $3.46M
-Gross PPE $6.60M $6.85M $7.03M $7.03M $5.93M
-Accumulated Depreciation -$3.06M -$2.89M -$2.71M -$2.71M -$2.47M
Non-Current Deferred Assets $1.70M $1.99M $2.18M $2.18M $2.20M
Other Non-Current Assets $3.27M $3.21M $2.58M $2.58M $2.06M
Total Liabilities $38.04M $37.27M $40.47M $40.47M $35.44M
Total Current Liabilities $17.20M $16.18M $19.19M $19.19M $15.17M
Payables $3.19M $1.98M $2.84M $2.84M $2.18M
-Accounts Payable $3.19M $1.98M $2.84M $2.84M $2.18M
Current Accrued Expenses $7.13M $9.84M $7.24M $7.24M $5.84M
Short-Term Debt and Capital Lease Obligation $1.18M $1.14M $1.11M $1.11M $1.18M
-Current Capital Lease Obligation $1.18M $1.14M $1.11M $1.11M $1.18M
Current Deferred Liabilities $11,000.00 $88,000.00 $101,000.00 $101,000.00 $136,000.00
Other Current Liabilities $343,000.00 $413,000.00 $818,000.00 $818,000.00 $766,000.00
Total Non-Current Liabilities $20.84M $21.08M $21.28M $21.28M $20.28M
Long Term Debt and Capital Lease Obligation $20.73M $20.98M $21.17M $21.17M $20.17M
-Long Term Debt $19.98M $19.92M $19.81M $19.81M $19.75M
-Long Term Capital Lease Obligation $748,000.00 $1.06M $1.36M $1.36M $422,000.00
Other Non-Current Liabilities $106,000.00 $106,000.00 $106,000.00 $106,000.00 $106,000.00
Total Equity $128.31M $140.81M $155.34M $155.34M $164.08M
Stockholders' Equity $128.31M $140.81M $155.34M $155.34M $164.08M
Capital Stock $39,000.00 $38,000.00 $38,000.00 $38,000.00 $38,000.00
-Common Stock $0.00 $0.00 $0.00 $0.00 $38,000.00
-Preferred Stock $39,000.00 $38,000.00 $38,000.00 $38,000.00 –
Additional Paid-In Capital $387.73M $380.85M $375.50M $375.50M $370.73M
Retained Earnings -$259.36M -$240.09M -$220.36M -$220.36M -$206.83M
Gains/Losses Not Affecting Retained Earnings -$92,000.00 $18,000.00 $159,000.00 $159,000.00 $139,000.00
Convertible preferred securities – $0.00 – – $0.00
Non-Current Deferred Liabilities – – $0.00 $0.00 $3,000.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$12.86M -$19.30M -$40.81M -$10.77M -$11.10M
Net cash flow from continuing operations -$12.86M -$19.30M -$40.81M -$10.77M -$11.10M
Net Income from Continuing Operations -$19.27M -$19.74M -$53.41M -$13.53M -$13.47M
Gain/Loss from Continuing Operations $28,000.00 $34,000.00 $104,000.00 $25,000.00 $29,000.00
Depreciation & Depletion & Amortization $245,000.00 $239,000.00 $1.34M $291,000.00 $391,000.00
Other Non-Cash Items $446,000.00 -$17,000.00 $314,000.00 $82,000.00 $80,000.00
Change in Working Capital $384,000.00 -$2.98M $633,000.00 -$382,000.00 -$580,000.00
-Change in Receivables -$46,000.00 -$575,000.00 -$4.89M -$2.91M -$198,000.00
-Change in Inventory $164,000.00 $386,000.00 -$351,000.00 -$1.26M -$24,000.00
-Change in Prepaid Assets -$777,000.00 $25,000.00 $345,000.00 -$46,000.00 -$838,000.00
-Change in Payables and Accrued Expense $1.12M -$2.81M $5.97M $4.06M $560,000.00
-Change in Other Current Assets $5,000.00 $6,000.00 -$415,000.00 -$194,000.00 $5,000.00
-Change In Other Working Capital -$77,000.00 -$13,000.00 -$26,000.00 -$37,000.00 -$85,000.00
Net cash flow from investing -$606,000.00 $22.44M -$118.14M $26.11M -$6.94M
Net Cash Flow from Continuing Investing Activities -$606,000.00 $22.44M -$118.14M $26.11M -$6.94M
Net PPE Purchase and Sale -$17,000.00 -$125,000.00 -$767,000.00 -$179,000.00 -$369,000.00
Net Investment Purchase and Sale -$382,000.00 $23.27M -$116.62M $26.66M -$6.48M
Financing Cash Flow $880,000.00 $1.63M $5.05M $1.40M $1.64M
Net Cash Flow from Continuing Financing Activities $880,000.00 $1.63M $5.05M $1.40M $1.64M
Proceeds from Stock Option Exercised $880,000.00 $1.63M $5.44M $1.64M $1.64M
Ending Cash Balance $32.66M $45.25M $40.48M $40.48M $23.74M
Net Change in Cash -$12.59M $4.78M -$153.89M $16.74M -$16.40M
Beginning Cash Balance $45.25M $40.48M $194.37M $23.74M $40.14M
Free Cash Flow -$12.18M -$20.12M -$41.58M -$10.95M -$11.47M
Net Intangibles Purchase and Sale – -$701,000.00 – – –
Net Other Investing Changes – – -$755,000.00 -$373,000.00 -$94,000.00
Net Issuance Payments Of Debt – – $0.00 $0.00 –
Net Common Stock Issuance – – $0.00 – –
Net Other Financing Charges – – -$386,000.00 -$236,000.00 $0.00

Discussion

No comments yet — be the first to weigh in on CBLL.

Sign in to join the discussion.

Scroll to Top